Ventas, Inc. $VTR Shares Sold by Banco Santander S.A.

Banco Santander S.A. cut its position in shares of Ventas, Inc. (NYSE:VTR) by 89.0% during the 3rd quarter, Holdings Channel reports. The firm owned 15,802 shares of the real estate investment trust’s stock after selling 127,956 shares during the period. Banco Santander S.A.’s holdings in Ventas were worth $1,106,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently modified their holdings of VTR. Vanguard Group Inc. raised its position in Ventas by 2.5% in the third quarter. Vanguard Group Inc. now owns 73,598,827 shares of the real estate investment trust’s stock worth $5,151,182,000 after acquiring an additional 1,802,515 shares in the last quarter. JPMorgan Chase & Co. grew its stake in shares of Ventas by 1.3% in the 3rd quarter. JPMorgan Chase & Co. now owns 29,701,300 shares of the real estate investment trust’s stock worth $2,078,794,000 after purchasing an additional 387,495 shares during the last quarter. State Street Corp raised its holdings in shares of Ventas by 5.2% in the 2nd quarter. State Street Corp now owns 27,998,629 shares of the real estate investment trust’s stock worth $1,781,267,000 after purchasing an additional 1,388,678 shares in the last quarter. Geode Capital Management LLC raised its holdings in shares of Ventas by 4.9% in the 2nd quarter. Geode Capital Management LLC now owns 12,226,283 shares of the real estate investment trust’s stock worth $769,061,000 after purchasing an additional 574,663 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. lifted its stake in Ventas by 6.3% during the second quarter. Charles Schwab Investment Management Inc. now owns 5,597,778 shares of the real estate investment trust’s stock valued at $353,500,000 after purchasing an additional 331,477 shares during the last quarter. Institutional investors own 94.18% of the company’s stock.

Ventas Stock Performance

Shares of Ventas stock opened at $86.38 on Friday. Ventas, Inc. has a 12 month low of $60.15 and a 12 month high of $87.87. The company has a quick ratio of 0.67, a current ratio of 0.67 and a debt-to-equity ratio of 1.03. The stock has a market cap of $41.03 billion, a PE ratio of 159.96, a price-to-earnings-growth ratio of 2.11 and a beta of 0.77. The business has a fifty day simple moving average of $80.00 and a 200-day simple moving average of $75.12.

Ventas (NYSE:VTR) last announced its quarterly earnings data on Thursday, February 5th. The real estate investment trust reported $0.15 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.89 by ($0.74). Ventas had a return on equity of 2.09% and a net margin of 4.31%.The business had revenue of ($1,229.71) million during the quarter, compared to analysts’ expectations of $1.53 billion. During the same period in the prior year, the company posted $0.81 earnings per share. The firm’s revenue was up 21.7% on a year-over-year basis. Ventas has set its FY 2026 guidance at 3.780-3.880 EPS. On average, sell-side analysts anticipate that Ventas, Inc. will post 3.4 EPS for the current fiscal year.

Ventas Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, April 16th. Investors of record on Tuesday, March 31st will be given a dividend of $0.52 per share. The ex-dividend date of this dividend is Tuesday, March 31st. This is a boost from Ventas’s previous quarterly dividend of $0.48. This represents a $2.08 dividend on an annualized basis and a yield of 2.4%. Ventas’s payout ratio is presently 355.56%.

Insider Buying and Selling at Ventas

In other news, CEO Debra A. Cafaro sold 10,322 shares of the business’s stock in a transaction on Monday, February 2nd. The shares were sold at an average price of $77.66, for a total transaction of $801,606.52. Following the transaction, the chief executive officer directly owned 1,114,034 shares in the company, valued at $86,515,880.44. The trade was a 0.92% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, CFO Robert F. Probst sold 29,930 shares of the company’s stock in a transaction on Friday, January 2nd. The stock was sold at an average price of $77.25, for a total transaction of $2,312,092.50. Following the completion of the transaction, the chief financial officer directly owned 138,434 shares in the company, valued at $10,694,026.50. This trade represents a 17.78% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last quarter, insiders have sold 86,106 shares of company stock worth $6,931,397. 0.80% of the stock is currently owned by company insiders.

Analysts Set New Price Targets

Several research analysts have issued reports on the stock. Morgan Stanley set a $90.00 price target on shares of Ventas in a research report on Friday, February 13th. KeyCorp raised their price objective on Ventas from $85.00 to $90.00 and gave the stock an “overweight” rating in a research note on Tuesday, February 10th. Weiss Ratings raised Ventas from a “hold (c+)” rating to a “buy (b-)” rating in a research report on Monday, December 29th. Jefferies Financial Group reiterated a “buy” rating and issued a $93.00 price target on shares of Ventas in a research report on Monday, December 15th. Finally, Royal Bank Of Canada lifted their price target on Ventas from $83.00 to $91.00 and gave the stock an “outperform” rating in a research note on Tuesday, February 10th. Thirteen research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $86.87.

About Ventas

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.